Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Synergy appoints Troy Hamilton head of commercial

This article was originally published in Scrip

Executive Summary

Synergy Pharmaceuticals has named Troy Hamilton chief commercial officer. Mr Hamilton will be responsible for Synergy’s overall commercial strategy and execution, and will implement marketing, sales, and commercial operations and infrastructure for the US launch of plecanatide, Synergy's lead gastrointestinal (GI) product. Prior to joining Synergy, he held multiple commercial leadership roles over a nine year period within Shire Pharmaceuticals' GI business unit. Most recently, he was vice-president of product strategy and commercial lead responsible for the GI motility, hepatology and pipeline products.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts